These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 16465008)

  • 41. [Comparison of cyclophosphamide and cyclosporine in the treatment of steroid-resistant idiopathic nephrotic syndrome in children].
    Rao J; Xu H; Cao Q; Huang WY; Zhou LJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):958-63. PubMed ID: 18182710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
    Inaba A; Hamasaki Y; Ishikura K; Hamada R; Sakai T; Hataya H; Komaki F; Kaneko T; Mori M; Honda M
    Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A clinicopathological study of idiopathic nephrotic syndrome in children.
    Lin JT; Lin CY; Huang FY; Lee PP; Chen CH; Hsu HC
    Nihon Jinzo Gakkai Shi; 1995 Aug; 37(8):442-50. PubMed ID: 7563952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of primary nephrotic syndrome in Egyptian children.
    Kaddah A; Sabry S; Emil E; El-Refaey M
    J Nephrol; 2012; 25(5):732-7. PubMed ID: 22101675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology.
    Watanabe Y; Fujinaga S; Endo A; Endo S; Nakagawa M; Sakuraya K
    Pediatr Nephrol; 2020 Dec; 35(12):2377-2381. PubMed ID: 32964318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
    Meyrier A
    J Nephrol; 1997; 10(1):14-24. PubMed ID: 9241620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome.
    Trachtman H; Greenbaum LA; McCarthy ET; Sharma M; Gauthier BG; Frank R; Warady B; Savin VJ
    Am J Kidney Dis; 2004 Oct; 44(4):604-10. PubMed ID: 15384010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporine experience in nephrotic syndrome.
    Phadke K; Ballal S; Maiya V
    Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
    Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence and clinicopathological profile of IgM nephropathy in children with steroid-resistant nephrotic syndrome at a single centre in Pakistan.
    Shakeel S; Mubarak M; Kazi JI; Lanewala A
    J Clin Pathol; 2012 Dec; 65(12):1072-6. PubMed ID: 22930793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
    Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
    Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
    Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
    Kim PK; Kim KS; Pai KS; Kim JH; Choi IJ
    Yonsei Med J; 1997 Oct; 38(5):307-18. PubMed ID: 9409194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
    Mishra OP; Kumar R; Narayan G; Srivastava P; Abhinay A; Prasad R; Singh A; Batra VV
    Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Nephrotic syndrome in childhood].
    Reusz G; Szabó A; Fekete A
    Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy.
    Peña A; Bravo J; Melgosa M; Fernandez C; Meseguer C; Espinosa L; Alonso A; Picazo ML; Navarro M
    Pediatr Nephrol; 2007 Nov; 22(11):1875-80. PubMed ID: 17876609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Childhood idiopathic steroid-resistant nephrotic syndrome at a Single Center in Khartoum.
    Ali EMA; Makki HFK; Abdelraheem MB; Makke SO; Allidir RA
    Saudi J Kidney Dis Transpl; 2017; 28(4):851-859. PubMed ID: 28748888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
    Prasher PK; Varma PP; Baliga KV
    J Assoc Physicians India; 1999 Feb; 47(2):180-2. PubMed ID: 10999084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
    Tune BM; Mendoza SA
    J Am Soc Nephrol; 1997 May; 8(5):824-32. PubMed ID: 9176855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome.
    Supavekin S; Surapaitoolkorn W; Kurupong T; Chaiyapak T; Piyaphanee N; Pattaragarn A; Sumboonnanonda A
    J Med Assoc Thai; 2013 Jan; 96(1):33-40. PubMed ID: 23720975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.